Detalhe da pesquisa
1.
The challenge of hypophosphatasia diagnosis in adults: results from the HPP International Working Group Literature Surveillance.
Osteoporos Int
; 35(3): 439-449, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37982856
2.
Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working Group.
Osteoporos Int
; 35(1): 1-10, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37982855
3.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE.
Endocr Pract
; 26(Suppl 1): 1-46, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32427503
4.
Romosozumab Treatment in Postmenopausal Women with Osteoporosis.
N Engl J Med
; 375(16): 1532-1543, 2016 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27641143
5.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS - 2016.
Endocr Pract
; 22(Suppl 4): 1-42, 2016 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27662240
6.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS - 2016--EXECUTIVE SUMMARY.
Endocr Pract
; 22(9): 1111-8, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27643923
7.
Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observed.
Bone
; 134: 115287, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32092479
8.
Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab Treatment.
J Clin Endocrinol Metab
; 104(8): 3450-3461, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31125092
9.
Vertebroplasty and kyphoplasty update.
Curr Osteoporos Rep
; 6(3): 114-9, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18752773
10.
Proceedings of the Eighth Annual Santa Fe Bone Symposium, August 3-4, 2007.
J Clin Densitom
; 11(2): 313-24, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18280193
11.
New and emerging concepts in the use of denosumab for the treatment of osteoporosis.
Ther Adv Musculoskelet Dis
; 10(11): 209-223, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30386439
12.
Hypophosphatasia in Adults: Clinical Assessment and Treatment Considerations.
J Bone Miner Res
; 32(10): 1977-1980, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28731215
13.
Western Osteoporosis Alliance Clinical Practice Series: Evaluating the Balance of Benefits and Risks of Long-Term Osteoporosis Therapies.
Am J Med
; 130(7): 862.e1-862.e7, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28359721
14.
Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday.
Am J Med
; 126(1): 13-20, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23177553
15.
Benefits and risks of bisphosphonate therapy for osteoporosis.
J Clin Endocrinol Metab
; 97(7): 2272-82, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22523337
16.
Safety of long-term bisphosphonate therapy for the management of osteoporosis.
Drugs
; 71(6): 791-814, 2011 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-21504254